HBM Healthcare Investments Stock

Detail Data
Volume (24h): 16,939 shares
P/E Ratio: 5.15
Forward P/E: 10.20
EPS: /
Forward EPS: /
Number of Shares: 6,771,780 shares
Market Capitalization: 1,124,115,456.00 CHF

Dividend

Dividend Value
Dividend Amount According to our data, the company HBM Healthcare Investments does not currently pay dividends.
Annual Yield %: -
Ex-dividend Date: -
5-Year Avg Yield %: -
Payout Ratio: -
Last Dividend Value: -
Last Dividend Date: -

Analyst Forecast

Most analysts have issued a strong_buy recommendation for HBM Healthcare Investments stock. The current number of analysts covering this company is 2. The highest target price is 236 CHF, while the lowest target price is 231 CHF. The median target valuation set by analysts is 233.5 CHF. These forecasts and recommendations provide insight into how analysts view the future stock performance of HBM Healthcare Investments.
Analysts Recommendation
Issued Recommendation: According to our data, the recommendation for HBM Healthcare Investments stock is: strong_buy
Number of Analysts: 2
Highest Target Price: 236 CHF
Lowest Target Price: 231 CHF
Median Target Price: 233.5 CHF

Fundamental Indicators

Indicator Data
Total Revenue: /
Net Income: /
Price-to-Book (P/B): /
PEG Ratio: /
Exchange: Swiss
Industry:
Sector:
Number of Employees:
Country:

Where to Buy HBM Healthcare Investments Stock?

You can purchase HBM Healthcare Investments stock on the Swiss under the ticker symbol: HBMN.SW. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

1

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5
Invest in Stocks with eToro
★★★★★ 5.0
2

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5
Try Free Demo Account
★★★★☆ 4.8
Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on HBM Healthcare Investments Stock

Indicator Value
Company Revenue: -
EBITDA: -
Earnings Per Share: -
Book Value Per Share: -
Total Cash: -
Total Cash per Share: -
Total Debt: -
Debt to Equity Ratio: -
Quick Ratio -
Current Ratio -
Free Cash Flow -
Operating Cash Flow -
Gross Margins -
EBITDA Margins -
Operating Margins -
Profit Margins -
Return on Assets -
Return on Equity -
Earnings Growth (1 year) -
Revenue Growth (1 year) -
Quarterly Earnings Year-over-Year Growth -
Market Capitalization 1,124,115,456.00 CHF
Enterprise Value -
EV/Revenue -
EV/EBITDA -
Float Shares -
Shares Outstanding -
Held Percent Insiders -
Held Percent Institutions -
Shares Short -
Shares Short Prior Month -
Date Short Interest -
Short Percentage of Total Shares -
Short Ratio -
Beta -
Short Percentage of Float -
Implied Shares Outstanding -

Frequently Asked Questions (FAQ)

According to our data, the company HBM Healthcare Investments does not pay dividends yet, even in 2025.

HBM Healthcare Investments shares are traded on the Swiss stock exchange under the ticker: HBMN.SW. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

According to our data, the recommendation for HBM Healthcare Investments shares is from a total of 2 analysts. The average target price prediction is 233.5 CHF per share.

The total number of HBM Healthcare Investments shares on the exchange is 0.00 shares, which at the current market capitalization gives the company a total valuation of 1,124,115,456.00 CHF.